N-Carbamylglutamate (Carbaglu) In The Treatment Of Hyperammonemia
Phase of Trial: Phase II/III
Latest Information Update: 07 May 2018
Price : $35 *
At a glance
- Drugs Carglumic acid (Primary)
- Indications Hyperammonaemia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 May 2018 Status changed from recruiting to completed.
- 25 Jan 2018 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.